Figure 4 summarizes a possible mode of action. A key point here is that VDAC1 binds many different proteins, including HK and components of the Bcl2/Bax, so it is also central in controlling cell fate and a target for cancer treatment (Shoshan-Barmatz et al., 2017). This evidence concerns the gene BAX and cancer.